Antiangiogenic therapy inhibits the recruitment of vascular accessory cells to the perivascular niche in glioma angiogenesis

Journal of Vascular Research

Volumn 51, Issue 2, 2014, Pages 102-109

  Parmaksiz, G ^a   Czabanka, M ^a   Vinci, M ^b   Vajkoczy, P ^a  

^a CHARITÉ UNIVERSITÄTSMEDIZIN BERLIN   (Germany)

^b INSTITUTE OF CANCER RESEARCH   (United Kingdom)

Author keywords

Antiangiogenic treatment; Sunitinib; Vascular accessory cells

Indexed keywords

PLATELET DERIVED GROWTH FACTOR RECEPTOR; SUNITINIB; VASCULOTROPIN RECEPTOR;

ACCESSORY CELL; ANGIOGENESIS; ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANTIANGIOGENIC THERAPY; ARTICLE; BLOOD FLOW VELOCITY; CAPILLARY DENSITY; CELL ADHESION; COMPUTER SYSTEM; CONTROLLED STUDY; ERYTHROCYTE; GLIOMA CELL; MICROSCOPE; MICROSCOPY; MOUSE; NONHUMAN; PERFUSION; PRIORITY JOURNAL; RAT; SHEAR RATE; SHEAR STRESS; SKINFOLD; STEM CELL NICHE; TREATMENT DURATION; VASCULAR ACCESSORY CELL; ADHESION; ANIMAL TISSUE; BLOOD VESSEL PERMEABILITY; BONE MARROW CELL; GLIOMA; HUMAN;

ANGIOGENESIS INHIBITORS; ANIMALS; BONE MARROW CELLS; BRAIN NEOPLASMS; CELL LINE, TUMOR; CELL MOVEMENT; GLIOMA; INDOLES; MICE; MICE, NUDE; NEOVASCULARIZATION, PATHOLOGIC; PYRROLES; RATS; TUMOR MARKERS, BIOLOGICAL; TUMOR MICROENVIRONMENT;

EID: 84895635478     PISSN: 10181172     EISSN: 14230135     Source Type: Journal    
DOI: 10.1159/000357620     Document Type: Article

References (39)

1. Bergers G, Hanahan D: Modes of resistance to anti-angiogenic therapy. Nat Rev Cancer 2008; 8: 592-603.
2. Loges S, Schmidt T, Carmeliet P: Mechanisms of resistance to anti-angiogenic therapy and development of third-generation anti-angiogenic drug candidates. Genes Cancer 2010; 1: 12-25.
3. Shojaei F, Wu X, Malik AK, Zhong C, Baldwin ME, Schanz S, Fuh G, Gerber HP, Ferrara N: Tumor refractoriness to anti- VEGF treatment is mediated by CD11b+ Gr1+ myeloid cells. Nat Biotechnol 2007; 25: 911-920.
4. Mancuso P, Calleri A, Bertolini F: Circulating endothelial cells and circulating endothelial progenitors. Recent Results Cancer Res 2012; 195: 163-170.
5. Timmermans F, Plum J, Yoder MC, Ingram DA, Vandekerckhove B, Case J: Endothelial progenitor cells: identity defined? J Cell Mol Med 2009; 13: 87-102.
6. Asahara T, Murohara T, Sullivan A, Silver M, van der Zee R, Li T, Witzenbichler B, Schatteman G, Isner JM: Isolation of putative progenitor endothelial cells for angiogenesis. Science 1997; 275: 964-967.
7. Grunewald M, Avraham I, Dor Y, Bachar-Lustig E, Itin A, Jung S, Chimenti S, Landsman L, Abramovitch R, Keshet E: VEGF-induced adult neovascularization: recruitment, retention, and role of accessory cells. Cell 2006; 124: 175-189.
8. Rafat N, Beck G, Schulte J, Tuettenberg J, Vajkoczy P: Circulating endothelial progenitor cells in malignant gliomas. J Neurosurg 2010; 112: 43-49.
9. Naik RP, Jin D, Chuang E, Gold EG, Tousimis EA, Moore AL, Christos PJ, de Dalmas T, Donovan D, Rafii S, Vahdat LT: Circulating endothelial progenitor cells correlate to stage in patients with invasive breast cancer. Breast Cancer Res Treat 2008; 107: 133-138.
10. Su Y, Zheng L, Wang Q, Li W, Cai Z, Xiong S, Bao J: Quantity and clinical relevance of circulating endothelial progenitor cells in human ovarian cancer. J Exp Clin Cancer Res 2010; 29: 27.
11. Dome B, Timar J, Dobos J, Meszaros L, Raso E, Paku S, Kenessey I, Ostoros G, Magyar M, Ladanyi A, Bogos K, Tovari J: Identification and clinical significance of circulating endothelial progenitor cells in human non-small cell lung cancer. Cancer Res 2006; 66: 7341-7347.
12. Shaked Y, Ciarrocchi A, Franco M, Lee CR, Man S, Cheung AM, Hicklin DJ, Chaplin D, Foster FS, Benezra R, Kerbel RS: Therapy-induced acute recruitment of circulating endothelial progenitor cells to tumors. Science 2006; 313: 1785-1787.
13. Shaked Y, Henke E, Roodhart JML, Mancuso P, Langenberg MHG, Colleoni M, Daenen LG, Man S, Xu P, Emmenegger U, Tang T, Zhu ZP, Witte L, Strieter RM, Bertolini F, Voest EE, Benezra R, Kerbell RS: Rapid chemotherapy- induced acute endothelial progenitor cell mobilization: implications for antiangiogenic drugs as chemosensitizing agents. Cancer Cell 2008; 14: 263-273.
14. Farace F, Massard C, Borghi E, Bidart JM, Soria JC: Vascular disrupting therapy-induced mobilization of circulating endothelial progenitor cells. Ann Oncol 2007; 18: 1421-1422.
15. Li B, Sharpe EE, Maupin AB, Teleron AA, Pyle AL, Carmeliet P, Young PP: VEGF and PIGF promote adult vasculogenesis by enhancing EPC recruitment and vessel formation at the site of tumor neovascularization. FASEB J 2006; 20: 1495-1497.
16. Ahluwalia MS, Gladson CL: Progress on antiangiogenic therapy for patients with malignant glioma. J Oncol 2010; 2010: 689018.
17. Chavakis E, Hain A, Vinci M, Carmona G, Bianchi ME, Vajkoczy P, Zeiher AM, Chavakis T, Dimmeler S: High-mobility group box 1 activates integrin-dependent homing of endothelial progenitor cells. Circ Res 2007; 100: 204-212.
18. Urbich C, Heeschen C, Aicher A, Sasaki K, Bruhl T, Farhadi MR, Vajkoczy P, Hofmann WK, Peters C, Pennacchio LA, Abolmaali ND, Chavakis E, Reinheckel T, Zeiher AM, Dimmeler S: Cathepsin L is required for endothelial progenitor cell-induced neovascularization. Nat Med 2005; 11: 206-213.
19. Vajkoczy P, Schilling L, Ullrich A, Schmiedek P, Menger MD: Characterization of angiogenesis and microcirculation of high-grade glioma: an intravital multifluorescence microscopic approach in the athymic nude mouse. J Cereb Blood Flow Metab 1998; 18: 510-520.
20. Vajkoczy P, Blum S, Lamparter M, Mailhammer R, Erber R, Engelhardt B, Vestweber D, Hatzopoulos AK: Multistep nature of microvascular recruitment of ex vivo-expanded embryonic endothelial progenitor cells during tumor angiogenesis. J Exp Med 2003; 197: 1755-1765.
21. Hatzopoulos AK, Folkman J, Vasile E, Eiselen GK, Rosenberg RD: Isolation and characterization of endothelial progenitor cells from mouse embryos. Development 1998; 125: 1457-1468.
22. Read TA, Farhadi M, Bjerkvig R, Olsen BR, Rokstad AM, Huszthy PC, Vajkoczy P: Intravital microscopy reveals novel antivascular and antitumor effects of endostatin delivered locally by alginate-encapsulated cells. Cancer Res 2001; 61: 6830-6837.
23. Baker M, Wayland H: On-line volume flow rate and velocity profile measurement for blood in microvessels. Microvasc Res 1974; 7: 131-143.
24. Ley K, Gaehtgens P: Endothelial, not hemodynamic, differences are responsible for preferential leukocyte rolling in rat mesenteric venules. Circ Res 1991; 69: 1034-1041.
25. Vajkoczy P, Menger MD, Vollmar B, Schilling L, Schmiedek P, Hirth KP, Ullrich A, Annie T, Fong T: Inhibition of tumor growth, angiogenesis, and microcirculation by the novel Flk-1 inhibitor SU5416 as assessed by intravital multi-fluorescence videomicroscopy. Neoplasia 1999; 1: 31-41.
26. Vajkoczy P, Schilling L, Ullrich A, Schmiedek P, Menger MD: Characterization of angiogenesis and microcirculation of high-grade glioma: an intravital multifluorescence microscopic approach in the athymic nude mouse. J Cereb Blood Flow Metab 1998; 18: 510-520.
27. Yoder MC, Ingram DA: The definition of EPCs and other bone marrow cells contributing to neoangiogenesis and tumor growth: is there common ground for understanding the roles of numerous marrow-derived cells in the neoangiogenic process? Biochim Biophys Acta 2009; 1796: 50-54.
28. Biancone L, Cantaluppi V, Duo D, Deregibus MC, Torre C, Camussi G: Role of L-selectin in the vascular homing of peripheral blood-derived endothelial progenitor cells. J Immunol 2004; 173: 5268-5274.
29. Tedder TF, Steeber DA, Chen A, Engel P: The selectins: vascular adhesion molecules. FASEB J 1995; 9: 866-873.
30. Chavakis E, Aicher A, Heeschen C, Sasaki K, Kaiser R, El Makhfi N, Urbich C, Peters T, Scharffetter-Kochanek K, Zeiher AM, Chavakis T, Dimmeler S: Role of beta2-integrins for homing and neovascularization capacity of endothelial progenitor cells. J Exp Med 2005; 201: 63-72.
31. Dentelli P, Rosso A, Balsamo A, Colmenares Benedetto S, Zeoli A, Pegoraro M, Camussi G, Pegoraro L, Brizzi MF: C-KIT, by interacting with the membrane-bound ligand, recruits endothelial progenitor cells to inflamed endothelium. Blood 2007; 109: 4264-4271.
32. Vajkoczy P, Farhadi M, Gaumann A, Heidenreich R, Erber R, Wunder A, Tonn JC, Menger MD, Breier G: Microtumor growth initiates angiogenic sprouting with simultaneous expression of VEGF, VEGF receptor-2, and angiopoietin-2. J Clin Invest 2002; 109: 777-785.
33. di Tomaso E, Snuderl M, Kamoun WS, Duda DG, Auluck PK, Fazlollahi L, Andronesi OC, Frosch MP, Wen PY, Plotkin SR, Hedley-Whyte ET, Sorensen AG, Batchelor TT, Jain RK: Glioblastoma recurrence after cediranib therapy in patients: lack of 'rebound' revascularization as mode of escape. Cancer Res 2011; 71: 19-28.
34. Urbich C, Walter DH, Zeiher AM, Dimmeler S: Laminar shear stress upregulates integrin expression: role in endothelial cell adhesion and apoptosis. Circ Res 2000; 87: 683-689.
35. Kim MB, Sarelius IH: Role of shear forces and adhesion molecule distribution on P-selectinmediated leukocyte rolling in postcapillary venules. Am J Physiol Heart Circ Physiol 2004; 287:H2705-H2711.
36. Czabanka M, Vinci M, Heppner F, Ullrich A, Vajkoczy P: Effects of sunitinib on tumor hemodynamics and delivery of chemotherapy. Int J Cancer 2009; 124: 1293-1300.
37. Zhang J, Zhao P, Fu Z, Chen X, Liu N, Lu A, Li R, Shi L, Pu P, Kang C, You Y: Glioma cells enhance endothelial progenitor cell angiogenesis via VEGFR-2, not VEGFR-1. Oncol Rep 2008; 20: 1457-1463.
38. Strojnik T, Kavalar R, Trinkaus M, Lah TT: Cathepsin L in glioma progression: comparison with cathepsin B. Cancer Detect Prev 2005; 29: 448-455.
39. Platt MO, Ankeny RF, Jo H: Laminar shear stress inhibits cathepsin L activity in endothelial cells. Arterioscler Thromb Vasc Biol 2006; 26: 1784-1790.